FI
ABBV icon

Financial Insights’s AbbVie ABBV Stock Holding History

Financial Insights’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524K Buy
2,083
+45
+2% +$9.68K 0.14% 87
2026
Q1 		$443K Buy
2,038
+62
+3% +$13.8K 0.14% 88
2025
Q4 		$451K Sell
1,976
-191
-9% -$43.5K 0.15% 80
2025
Q3 		$502K Buy
2,167
+40
+2% +$8.15K 0.17% 70
2025
Q2 		$395K Buy
2,127
+618
+41% +$115K 0.14% 80
2025
Q1 		$316K Buy
1,509
+10
+0.7% +$1.94K 0.13% 77
2024
Q4 		$266K Sell
1,499
-69
-4% -$12.7K 0.1% 90
2024
Q3 		$310K Buy
1,568
+10
+0.6% +$1.87K 0.1% 110
2024
Q2 		$267K Buy
1,558
+185
+13% +$30.6K 0.07% 139
2024
Q1 		$250K Buy
+1,373
New +$237K 0.07% 150
2021
Q3 		– Sell
-1,070
Closed -$121K – 81
2021
Q2 		$121K Buy
+1,070
New +$121K 0.1% 110

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Financial Insights's ABBV Position: Q2 2026 in Review

Financial Insights increased its AbbVie (ABBV) stake by 2.2% in Q2 2026, buying an estimated $9.68K and bringing the position to 2,083 shares worth $524K. The position accounts for 0.14% of the portfolio, ranked #87.

Financial Insights first reported a position in ABBV in Q2 2021 and has held it in 11 quarters since. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Financial Insights held 2,083 shares of AbbVie worth $524K as of Q2 2026.
  • Financial Insights bought 45 AbbVie shares in Q2 2026, an estimated $9.68K.
  • AbbVie made up 0.14% of Financial Insights's portfolio in Q2 2026, its #87 holding.
  • Financial Insights first reported a position in AbbVie in Q2 2021 and has held it in 11 quarters since.
  • 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Financial Insights's 13F filing for Q2 2026, filed 25 Aug 2026.